NYSE · Health care

Nanoviricides, Inc. (NNVC)

It posted a net loss of $8.1M. In fiscal 2025 capital spending exceeded operating cash flow by $8.5M. At March 31, 2026 it held $3.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on May 15, 2026.

Price

$1.44

0.00% on the day · September 25, 2026

52-week range $0.85 to $2.23

Market cap

$36.6M

What Nanoviricides, Inc. does

Nanoviricides, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker NNVC.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	$0	-$9.6M	-$9.5M	-$0.63	-$8.5M
2024	$0	-$8.5M	-$8.3M	-$0.70	-$6.5M
2023	$0	-$8.9M	-$8.6M	-$0.74	-$5.8M
2022	n/a	-$8.1M	-$8.1M	-$0.70	-$6.2M
2021	n/a	-$8.7M	-$8.8M	-$0.81	-$8.5M
2020	n/a	-$8M	-$13.4M	-$2.39	-$6.7M

Full financial statements: income, balance sheet and cash flow

Next report expected around September 28, 2026.

Estimated from its filing rhythm: 52 weeks after its report of September 29, 2025. Not a date the company has announced. See the report calendar

Latest SEC filings

What Nanoviricides, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 3, 2026
Securities offering prospectus 424B3
August 21, 2026
Shelf registration to sell securities S-3
July 30, 2026
Material agreement 8-K
July 27, 2026
Securities offering prospectus 424B5
July 27, 2026
Securities offering prospectus 424B5
July 17, 2026
Material agreement 8-K
July 17, 2026
Securities offering prospectus 424B5
July 1, 2026
Securities offering prospectus 424B3
June 22, 2026
Form DEL AM filing DEL AM
June 17, 2026
Form DEL AM filing DEL AM

Recent insider filings (Forms 3, 4 and 144): 10, the latest on January 28, 2025. Insider transactions on SEC

All filings on SEC EDGAR

Questions about NNVC

What does Nanoviricides, Inc. do?

Nanoviricides, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker NNVC.

Is Nanoviricides, Inc. profitable?

No. Over the twelve months to March 31, 2026 it reported a net loss of $8.1M.

When did Nanoviricides, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on May 15, 2026. It covers the period to March 31, 2026. Its newest filing of any kind is the securities offering prospectus from September 3, 2026.

Similar companies

Compare NNVC with

Compare NNVC with any company

Follow NNVC

Get an email when Nanoviricides, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow NNVC: get an email when it files

Where the numbers come from

Financial figures are the values Nanoviricides, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.